Skip to search formSkip to main contentSkip to account menu

CD109 gene

Known as: CPAMD7, DKFZp762L1111, FLJ38569 
This gene may be involved in both signal regulation and inhibition of proteolysis.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Cluster of differentiation (CD) 109 is a glycosylphosphatidylinositol-anchored cell surface glycoprotein and a co-receptor for… 
2016
2016
BackgroundHepatocellular carcinoma (HCC) accounts for 75–80 % of primary liver cancer, and usually arises after years of liver… 
2016
2016
SummaryTransforming growth factor (TGF)-β signaling plays an important role in the pathogenesis of psoriasis. CD109, a novel TGF… 
2015
2015
To the Editor, Esophageal squamous cell carcinoma (ESCC) accounts for approximately one-sixth of all cancer-related mortality… 
2014
2014
Background The development of novel targeted cancer therapies and/or diagnostic tools is dependent upon an understanding of the… 
2014
2014
CD109, a glycosylphosphatidylinositol-anchored glycoprotein, is expressed at high levels in some human tumors including squamous… 
2014
2014
Background The endothelium is not a homogeneous organ. Endothelial cell heterogeneity has been described at the level of cell… 
2011
2011
Background and Objectives: The frequencies of human platelet antigens (HPAs) vary between different populations. In this study… 
2010
2010
Bladder cancer is one of the most common malignant diseases. Since a high‐rate of recurrence is a serious problem for early stage… 
2004
2004
We report here the genomic organization and phylogenic relationships of CD109, a member of the the alpha2-macroglobulin…